82.6
Inmune Bio, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
64.7
FY23:
39.9
FY24:
22.7
FY25:
29.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
17.3
FY22:
17.1
FY23:
17.1
FY24:
16.9
FY25:
2.46
Total assets
Change from FY21 to FY25
millions USD
FY21:
99.9
FY22:
81.8
FY23:
57.0
FY24:
39.6
FY25:
32.4
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
4.36
FY22:
10.9
FY23:
18.5
FY24:
7.22
FY25:
8.42
(negative)
Change from FY21 to FY25
millions USD
FY21:
15.4
FY22:
10.8
FY23:
0.40
FY24:
0.24
FY25:
0.41
(positive)
Change from FY21 to FY25
millions USD
FY21:
80.2
FY22:
60.1
FY23:
37.3
FY24:
32.1
FY25:
23.5
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
99.9
FY22:
81.8
FY23:
56.2
FY24:
39.6
FY25:
32.4
All amounts in millions USD